首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1828234

2025年全球智慧切片檢查設備市場報告

Smart Biopsy Devices Global Market Report 2025

出版日期: 2025年09月11日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，智慧切片檢查設備市場呈現強勁成長勢頭，市場規模將從2024年的28.5億美元成長至2025年的30.1億美元，複合年成長率為5.6%。預測期內的成長歸因於癌症患者數量的增加、對微創手術的需求、醫療設備的創新以及診斷準確性的提高。

預計未來幾年智慧切片檢查設備市場將強勁成長，到2029年將達到40.1億美元，複合年成長率為7.4%。預測期內的成長歸因於個人化醫療的發展、診斷影像模式的進步、切片檢查在生物標記分析中的應用增加、新參與企業的進入以及數據連接性的增強。預測期內的主要趨勢包括機器人輔助切片檢查、人工智慧輔助切片檢查、無線切片檢查工具的開發、可攜式手持設備和即時引導系統。

智慧切片檢查設備是一種智慧儀器，旨在提高醫療過程中組織取樣的準確性和效率，通常包含影像引導、即時回饋和機器人輔助等功能。這些設備旨在提高診斷能力和患者預後，尤其是在癌症診斷和藥物傳輸方面。

智慧切片檢查設備類別的關鍵產品包括針切片檢查設備、操作托盤和定位導絲。針吸活體組織切片設備用於從骨骼、肌肉、肝臟和肺部等各種器官採集組織和體液樣本，並從體內提取細胞樣本進行實驗室分析。這些設備採用超音波引導切片檢查、立體定位切片檢查和磁振造影引導切片檢查等引導技術。智慧切片檢查設備應用於乳癌、皮膚癌、肝癌和攝護腺癌等多個領域。這些設備的最終用戶包括醫院、學術研究機構、診斷中心和影像中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

智慧切片檢查設備研究報告是商業研究公司 (The Business 切片檢查 Company) 最新報告系列之一，提供智慧切片檢查設備市場統計數據，例如全球市場規模、區域佔有率、競爭對手的智慧切片檢查設備市場佔有率、智慧切片檢查設備細分市場的詳細情況、市場趨勢以及智慧活體組織切片設備行業的商機。這份智慧切片檢查設備市場研究報告對該行業的現狀和未來走勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年7.4%的預測成長率比我們先前對該市場的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，導致微電子機械切割裝置和即時影像感測器（主要從德國和日本進口）成本上升，從而導致精密組織採樣程序的價格上漲。此外，由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

癌症發生率的上升預計將推動未來智慧切片檢查設備市場的成長。癌症涵蓋多種疾病，幾乎可發生在體內任何器官或組織中，原因是異常細胞不受控制地增殖，突破正常界限，轉移到其他器官或侵入鄰近組織。癌症患者數量的增加推動了對精準、有針對性的組織樣本的需求。這種需求推動了智慧切片檢查設備的開發和改進，這些設備具有先進的分子、成像和精準功能，以支援診斷和治療計劃。例如，2024 年 1 月，總部位於瑞士的政府間組織世界衛生組織 (WHO) 預測，到 2050 年，全球新增癌症病例將超過 3,500 萬例，比 2022 年記錄的預計 2,000 萬例和 970 萬例死亡病例增加 77%。因此，癌症患者數量的增加正在推動智慧切片檢查市場的成長。

微創手術的採用預計將顯著促進智慧切片檢查設備市場的成長。微創手術旨在最大限度地減少對正常身體結構的破壞，而使用智慧切片檢查設備可以提高組織取樣的精確度和準確度。這些設備通常採用先進的成像技術，例如超音波和核磁共振引導，使醫護人員能夠透過較小的切口針對特定區域進行切片檢查。這減少了患者的創傷並提高了診斷的準確性。例如，根據經濟合作暨發展組織2023 年 10 月發布的數據，捷克共和國的白內障手術數量預計將從 2021 年的 131,612 例增加 8.4%，到 2022 年增加到 142,670 例。因此，微創手術的日益普及正在推動智慧切片檢查設備市場的發展。

智慧切片檢查設備市場由提供切片檢查樣本採集、即時癌症組織表徵、微創切片檢查和精準組織定位等服務的營業單位所獲得的收益組成。市場規模還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。智慧切片檢查設備市場還包括用於提供切片檢查樣本採集和即時癌症組織表徵服務的影像引導切片檢查設備、核心切片檢查設備、骨骼切片穿刺針和設備以及分子切片檢查設備的銷售。此市場價值是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

全球智慧切片檢查設備：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
最終用途產業分析
全球智慧切片檢查設備市場：成長率分析
全球智慧切片檢查設備市場表現：規模與成長，2019-2024
全球智慧切片檢查設備市場預測：規模與成長，2024-2029 年，2034 年
全球智慧切片檢查設備：總目標市場（TAM）

第6章市場細分

全球智慧切片檢查設備市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
針切片檢查切片裝置
治療托盤
本地化線路
其他
全球智慧切片檢查設備市場（按指導技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
超音波引導下切片檢查
立體定位引導切片檢查
磁振造影切片檢查
其他
全球智慧切片檢查設備市場應用、效能及預測（2019-2024、2024-2029、2034）
乳癌
皮膚癌
肝癌
攝護腺癌
其他
全球智慧切片檢查設備市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
醫院
學術研究機構
診斷和影像中心
全球智慧切片檢查設備市場：針切片檢查設備細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
芯針切片裝置
細針抽吸（FNA）裝置
真空輔助切片檢查裝置
全球智慧切片檢查設備市場：手術托盤細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
預包裝切片檢查程序托盤
可客製化的治療托盤
全球智慧切片檢查設備市場：定位線細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
鉤絲定位裝置
雷達定位裝置
磁定位裝置
全球智慧切片檢查設備市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
切片檢查標記物
切片檢查成像系統
切片檢查引導系統

第7章區域和國家分析

全球智慧切片檢查設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
全球智慧切片檢查設備市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

智慧切片檢查設備市場：競爭格局
智慧切片檢查設備市場：公司簡介
- Cardinal Health Inc
- General Electric Company
- Medtronic Plc
- Danaher Corporation
- Canon Medical Systems Corporation

第31章：其他領先和創新企業

Toshiba Corporation
Siemens Healthineers
FUJIFILM Holdings Corporation
Becton Dickinson and Company
Boston Scientific Corporation
B. Braun Melsungen AG
Olympus Corporation
Intuitive Surgical Inc.
Hologic Inc.
Cook Medical Inc.
CONMED Corporation
Leica Biosystems
Argon Medical Devices Inc.
Esaote SpA
SOMATEX Medical Technologies GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

2029年智慧切片檢查設備市場：提供新機會的國家
2029 年智慧切片檢查設備市場：細分市場將帶來新機會
2029年智慧切片檢查設備市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r25310u

Smart biopsy devices are intelligent instruments designed to enhance the precision and efficiency of tissue sampling during medical procedures, often incorporating features such as image guidance, real-time feedback, or robotic assistance. These devices aim to improve diagnostic capabilities and patient outcomes, particularly in the context of cancer diagnosis and drug delivery.

The primary products within the category of smart biopsy devices include needle-based biopsy instruments, procedure trays, localization wires, and others. Needle-based biopsy instruments are tools used to extract a sample of the body's cells for laboratory analysis, collecting tissue or liquid samples from various organs such as bones, muscles, liver, and lungs. These devices employ guidance techniques such as ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and others. Smart biopsy devices find applications in various areas, including breast cancer, skin cancer, liver cancer, prostate cancer, and more. The end users of these devices include hospitals, academic and research institutes, as well as diagnostic and imaging centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The smart biopsy devices research report is one of a series of new reports from The Business Research Company that provides smart biopsy devices market statistics, including the smart biopsy devices industry's global market size, regional shares, competitors with smart biopsy devices market share, detailed smart biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the smart biopsy devices industry. This smart biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart biopsy devices market size has grown strongly in recent years. It will grow from $2.85 billion in 2024 to $3.01 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased cancer cases, demand for minimally invasive procedures, innovations in medical devices, improved diagnostic accuracy.

The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine growth, advancements in imaging modalities, rise in biopsy for biomarker analysis, market entry of new players, enhanced data connectivity. Major trends in the forecast period include robot-assisted biopsies, ai-driven biopsy assistance, development of wireless biopsy tools, portable and handheld devices, real-time guidance systems.

The forecast of 7.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased costs for micro-electromechanical cutting mechanisms and real-time imaging sensors, primarily imported from Germany and Japan, leading to higher prices for precision tissue sampling procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cancer is anticipated to drive the growth of the smart biopsy devices market in the future. Cancer encompasses a wide range of diseases that can occur in nearly any organ or tissue in the body when abnormal cells grow uncontrollably, breach their usual boundaries, and either spread to other organs or invade nearby tissues. The rising number of cancer cases has led to a greater demand for precise and targeted tissue samples. This demand has spurred the development and enhancement of smart biopsy devices featuring advanced molecular, imaging, and precision capabilities to support diagnosis and treatment planning. For example, in January 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that there will be over 35 million new cancer cases by 2050, representing a 77% increase from the estimated 20 million cases and 9.7 million deaths recorded in 2022. Therefore, the rising number of cancer cases is driving the growth of the smart biopsy device market.

The adoption of minimally invasive procedures is poised to contribute significantly to the growth of the smart biopsy devices market. Minimally invasive procedures, designed to minimize disruption to the body's normal structures, benefit from the use of smart biopsy devices to enhance precision and accuracy in tissue sampling. These devices often incorporate advanced imaging technologies such as real-time ultrasound or MRI guidance, enabling healthcare professionals to target specific areas for biopsy through smaller incisions. This reduces patient trauma and enhances diagnostic accuracy. For instance, data from the Organization for Economic Co-operation and Development in October 2023 revealed an 8.4% increase in cataract surgical procedures in the Czech Republic, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Therefore, the growing adoption of minimally invasive procedures is a driving factor in the smart biopsy devices market.

Major companies in the smart biopsy device market are developing advanced products, such as breast biopsy markers, to enhance the accuracy and effectiveness of breast cancer diagnostics. These markers are specifically designed to accurately identify the location of a tissue sample collected during a biopsy, assisting in future treatments and ensuring that the appropriate area is monitored for potential malignancy. For example, in August 2022, Mammotome, a US-based medical device company, introduced the Mammotome DualCore Dual Stage Core Biopsy System. This minimally invasive breast biopsy device employs a dual-stage process to deliver precise, high-quality tissue samples and is frequently used with ultrasound guidance to ensure accurate, safe, and efficient breast cancer diagnosis. Additionally, this system can be paired with advanced breast biopsy markers, providing clinicians with a comprehensive and innovative solution for ultrasound-guided breast biopsies.

Major companies in the smart biopsy devices market are introducing new products, such as dual-stage core biopsy instruments, to gain a competitive advantage. Dual-stage core biopsy involves a two-step process, starting with the acquisition stage, where the biopsy instrument is guided to obtain a tissue sample, followed by the extraction stage to retrieve the obtained tissue for diagnostic analysis. For instance, Mammotome, a breast cancer care solutions company, launched the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. This advanced system offers three programmable firing modes and one-handed operation, providing clinicians with a versatile tool for accessing challenging lesions. The system's ergonomic design minimizes needle movements and vibrations, enhancing the overall patient experience.

In June 2023, Quest Diagnostics, a medical laboratories company, acquired Haystack Oncology for $450 million. This strategic acquisition enhances Quest Diagnostics' cancer diagnostics portfolio by incorporating Haystack's highly sensitive minimal-residual disease (MRD) testing technology based on circulating tumor DNA (ctDNA). The addition of Haystack's advanced testing capabilities allows Quest to offer improved early detection of solid tumor cancers through blood-based clinical lab services, starting in 2024. Haystack Oncology Inc. specializes in developing and utilizing advanced technologies for MRD testing in the field of cancer diagnostics.

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart biopsy devices market consists of revenues earned by entities by providing services such as collecting biopsy samples, real-time cancer tissue characterization, minimally invasive biopsy, and precise tissue targeting. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart biopsy devices market also includes sales of image-guided biopsy devices, core biopsy devices, bone biopsy needles and devices, and molecular biopsy devices which are used in providing collecting biopsy samples, real-time cancer tissue characterization services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Biopsy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart biopsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart biopsy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Needle-Based Biopsy Instruments; Procedure Trays; Localization Wires; Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy; Stereotactic-Guided Biopsy; Magnetic Resonance Imaging-Guided Biopsy; Other Guidance Techniques
3) By Application: Breast Cancer; Skin Cancer; Liver Cancer; Prostate Cancer; Other Applications
4) By End-User: Hospitals; Academic And Research Institutes; Diagnostic And Imaging Centers
Subsegments:
1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices; Fine Needle Aspiration (FNA) Devices; Vacuum-Assisted Biopsy Devices
2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays; Customizable Procedure Trays
3) By Localization Wires: Hook Wire Localization Devices; Radar Localization Devices; Magnetic Localization Devices
4) By Other Products: Biopsy Markers; Biopsy Imaging Systems; Biopsy Guidance Systems
Companies Mentioned: Cardinal Health Inc; General Electric Company; Medtronic Plc; Danaher Corporation; Canon Medical Systems Corporation; Toshiba Corporation; Siemens Healthineers; FUJIFILM Holdings Corporation; Becton Dickinson and Company; Boston Scientific Corporation; B. Braun Melsungen AG; Olympus Corporation; Intuitive Surgical Inc.; Hologic Inc.; Cook Medical Inc.; CONMED Corporation; Leica Biosystems; Argon Medical Devices Inc.; Esaote SpA; SOMATEX Medical Technologies GmbH; Planmed Oy; TSK Laboratory Europe B.V.; DTR Medical Ltd.; INRAD Inc.; Sterylab Srl; EndoMed Systems GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Smart Biopsy Devices Market Characteristics

3. Smart Biopsy Devices Market Trends And Strategies

4. Smart Biopsy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Smart Biopsy Devices Growth Analysis And Strategic Analysis Framework

5.1. Global Smart Biopsy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Smart Biopsy Devices Market Growth Rate Analysis
5.4. Global Smart Biopsy Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Smart Biopsy Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Smart Biopsy Devices Total Addressable Market (TAM)

6. Smart Biopsy Devices Market Segmentation

6.1. Global Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Needle-Based Biopsy Instruments
Procedure Trays
Localization Wires
Other Products
6.2. Global Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ultrasound-Guided Biopsy
Stereotactic-Guided Biopsy
Magnetic Resonance Imaging-Guided Biopsy
Other Guidance Techniques
6.3. Global Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast Cancer
Skin Cancer
Liver Cancer
Prostate Cancer
Other Applications
6.4. Global Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Academic And Research Institutes
Diagnostic And Imaging Centers
6.5. Global Smart Biopsy Devices Market, Sub-Segmentation Of Needle-Based Biopsy Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Core Needle Biopsy Devices
Fine Needle Aspiration (FNA) Devices
Vacuum-Assisted Biopsy Devices
6.6. Global Smart Biopsy Devices Market, Sub-Segmentation Of Procedure Trays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-Packaged Biopsy Procedure Trays
Customizable Procedure Trays
6.7. Global Smart Biopsy Devices Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hook Wire Localization Devices
Radar Localization Devices
Magnetic Localization Devices
6.8. Global Smart Biopsy Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biopsy Markers
Biopsy Imaging Systems
Biopsy Guidance Systems

7. Smart Biopsy Devices Market Regional And Country Analysis

7.1. Global Smart Biopsy Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Smart Biopsy Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Biopsy Devices Market

8.1. Asia-Pacific Smart Biopsy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Biopsy Devices Market

9.1. China Smart Biopsy Devices Market Overview
9.2. China Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Biopsy Devices Market

10.1. India Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Biopsy Devices Market

11.1. Japan Smart Biopsy Devices Market Overview
11.2. Japan Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Biopsy Devices Market

12.1. Australia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Biopsy Devices Market

13.1. Indonesia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Biopsy Devices Market

14.1. South Korea Smart Biopsy Devices Market Overview
14.2. South Korea Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Biopsy Devices Market

15.1. Western Europe Smart Biopsy Devices Market Overview
15.2. Western Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Biopsy Devices Market

16.1. UK Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Biopsy Devices Market

17.1. Germany Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Biopsy Devices Market

18.1. France Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Biopsy Devices Market

19.1. Italy Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Biopsy Devices Market

20.1. Spain Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Biopsy Devices Market

21.1. Eastern Europe Smart Biopsy Devices Market Overview
21.2. Eastern Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Biopsy Devices Market

22.1. Russia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Biopsy Devices Market

23.1. North America Smart Biopsy Devices Market Overview
23.2. North America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Biopsy Devices Market

24.1. USA Smart Biopsy Devices Market Overview
24.2. USA Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Biopsy Devices Market

25.1. Canada Smart Biopsy Devices Market Overview
25.2. Canada Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Biopsy Devices Market

26.1. South America Smart Biopsy Devices Market Overview
26.2. South America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Biopsy Devices Market

27.1. Brazil Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Biopsy Devices Market

28.1. Middle East Smart Biopsy Devices Market Overview
28.2. Middle East Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Biopsy Devices Market

29.1. Africa Smart Biopsy Devices Market Overview
29.2. Africa Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Biopsy Devices Market Competitive Landscape And Company Profiles

30.1. Smart Biopsy Devices Market Competitive Landscape
30.2. Smart Biopsy Devices Market Company Profiles
- 30.2.1. Cardinal Health Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Smart Biopsy Devices Market Other Major And Innovative Companies

31.1. Toshiba Corporation
31.2. Siemens Healthineers
31.3. FUJIFILM Holdings Corporation
31.4. Becton Dickinson and Company
31.5. Boston Scientific Corporation
31.6. B. Braun Melsungen AG
31.7. Olympus Corporation
31.8. Intuitive Surgical Inc.
31.9. Hologic Inc.
31.10. Cook Medical Inc.
31.11. CONMED Corporation
31.12. Leica Biosystems
31.13. Argon Medical Devices Inc.
31.14. Esaote SpA
31.15. SOMATEX Medical Technologies GmbH

32. Global Smart Biopsy Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Biopsy Devices Market

34. Recent Developments In The Smart Biopsy Devices Market

35. Smart Biopsy Devices Market High Potential Countries, Segments and Strategies

35.1 Smart Biopsy Devices Market In 2029 - Countries Offering Most New Opportunities
35.2 Smart Biopsy Devices Market In 2029 - Segments Offering Most New Opportunities
35.3 Smart Biopsy Devices Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies